OrthoSensor, Inc., a Sunrise, FL-based medical device company developing and commercializing intelligent orthopedic devices, has closed on an additional $15m in Series B financing.
This investment, made by unnamed backers, brings the total Series B round to $36m.
The company intends to use the funding to expand the commercialization of its first product, the OrthoSensor™ Knee Balancer, and to support the launch of its line of additional intelligent orthopedic devices.
Led by CEO Jay Pierce, OrthoSensor has three product platforms: OrthoSensor Surgical, OrthoSensor Implantables and OrthoSensor Analytics. Its first product is the OrthoSensor™ Knee Balancer, which is used to insure proper soft tissue balance during total knee arthroplasty. It is embedded with sensors that provide surgeons with actionable data on implant fit and knee kinematics.